Literature DB >> 27508262

Data on pro-inflammatory cytokines IL-1β, IL-17, and IL-6 in the peripheral blood of HIV-infected individuals.

Tommy Saing1, Anddre Valdivia1, Parveen Hussain1, Judy Ly1, Leslie Gonzalez1, Frederick T Guilford2, Daniel Pearce3, Vishwanath Venketaraman4.   

Abstract

Our most recent data indicate differences in the levels of pro-inflammatory cytokines (IL-1β, IL-17, and IL-6) and malondialdehyde (MDA), a stable end-product of lipid peroxidation in the plasma samples between HIV positive individuals with low CD4 T cell counts <200 mm(3) and HIV positive individuals with CD4 T cell counts between 200 and 300 mm(3) (ee). The data lend support and provide valuable correlation between CD4 T cell counts and the levels of inflammatory cytokines in HIV positive individuals.

Entities:  

Keywords:  Cytokines; HIV; Inflammation; Oxidative stress

Year:  2016        PMID: 27508262      PMCID: PMC4969237          DOI: 10.1016/j.dib.2016.07.023

Source DB:  PubMed          Journal:  Data Brief        ISSN: 2352-3409


Specifications Table

Value of the data

The data is important as it can provide researchers and medical practitioners a better understanding of the changes in the levels of pro-inflammatory cytokines and free radicals in HIV positive subjects with CD4 T cell counts <200 mm3 [n=15] and those with CD4 T cell counts >200 mm3 [n=15]. The data shown in this article compares the levels of IL-1β, IL-17, IL-6 and MDA in the peripheral blood from HIV-1 positive individuals to the levels in healthy subjects [4], [5]. The findings may help understand the consequence of CD4 T cell decline in the pathophysiology of the disease process. Redox imbalance and exacerbated inflammation in HIV-1 positive individuals contribute to increased susceptibility for opportunistic infections [1], [2], [3]. These data could help researchers develop novel immunotherapeutics to modulate the host immune responses.

Data

Our data indicates a correlation between diminished CD4 T cell counts and increased levels of pro-inflammatory cytokines (IL-1β, IL-17, and IL-6) that contribute to systemic inflammation and cell signaling [1], [2]. Our methodology for the measurement of these cytokines is colorimetric ELISA detection kits as previously reported [1], [2], [3]. The data that we presented here contribute to the understanding of the pathophysiology of the disease process in individuals with HIV-1 infection (Fig. 1, Fig. 2).
Fig. 1

Levels of IL-1β and IL-17 in plasma from HIV-1 individuals with CD4 T cell counts >200 mm3 and CD4 T cell <200 mm3. Average values in normal healthy individuals range between 2.04±4.93 pg/mL [4]. Here we present values that show levels of IL-1β to be significantly higher in HIV-1 individuals with CD4 T cell <200 mm3 compared to CD4 T cell >200 mm3 (A). Data for IL-17 showed HIV-1 subjects with CD4 T cell <200 mm3 had significantly higher levels than subjects with CD4 T cell >200 mm3 (B). The average values found in peripheral blood of normal healthy individuals for IL-17 range between 6.53±7.42 pg/mL [4]. P-value *p<0.05.

Fig. 2

Levels of IL-6 and MDA in plasma samples from HIV-1 individuals with CD4 T cell >200 mm3 and CD4 T cell <200 mm3. HIV-1 subjects with CD4 T cell <200 mm3 had significantly higher levels of IL-6 than subjects with CD4 T cell >200 mm3 (A). Average values of IL-6 in healthy individuals range between 2.91±6.45 pg/mL [4]. Although it was not significant, levels of MDA were similar between HIV-1 subjects with CD4 T cell >200 mm3 and with CD4 T cell <200 mm3 (B). Levels of MDA from healthy subjects are significantly lower than HIV infected individuals [1], [2], [5]. P-value, *p<0.05.

Experimental design, materials and methods

Study subjects and blood specimens collection

The Institutional Review Board of Western University of Health Sciences approved the research protocol. Blood specimens were obtained from HIV-1 positive participants recruited at the Riverside County Regional Medical Center, Moreno Valley, CA. Study subjects were under 65 years of ago with no preference for gender and ethnicity. Isolation of Plasma from Whole Blood. Whole blood was collected from each subject and processed according to the method reported by our lab [1], [2]. Plasma samples were obtained from whole blood by performing density gradient centrifugation using Ficoll-Paque PLUS (10040757; GE Health care).

Malondialdehyde (MDA) measurement for oxidative stress

MDA is a byproduct of lipid peroxidation and is used to determine the levels of oxidative stress in the cells. A colorimetric is observed at 530–540 nm when MDA forms an adduct with thiobarbituric acid. Detailed protocol was previously reported [1], [2], [3].

Statistical analysis

Statistical data were analyzed using Graph Pad Prism Software. All data were reported in means P-values (p<0.05), using unpaired t-test with Welch׳s correction.
Subject areaBiology
More specific subject areaImmunology, Infectious disease, oxidative stress
Type of dataFigures
How data was acquiredData were obtained by using the Microplate Reader Instrument (Bio-Tek Multi-mode Instrument, VT, USA), KC4 Data Collection Software, and analyzed with Graph Pad Prism.
Data formatRaw and analyzed
Experimental factorsWhole blood from HIV-1 subjects with CD4 T cell counts <200 mm3 [n=15] and CD4 T cell counts 200–300 mm3 will be referred as CD4>200} [n=15] were obtained from the Riverside County Regional Medical Center in Moreno Valley, CA.
Experimental featuresWhole blood specimen was processed using density gradient centrifugation in order to obtain plasma samples. ELISA and colorimetric kits were used for determining the levels of pro-inflammatory cytokines (IL-1β, IL-17, and IL-6) and MDA in the plasma obtained from individuals with HIV-1 infection.
Data source locationDepartment of Basic Medical Sciences, College of Osteopathic Medicine of the Pacific and Graduate College of Biological Sciences Western University of Health Sciences, Pomona, CA 91766.
Data accessibilityData are in this article
  5 in total

1.  Serum cytokine profiles in healthy young and elderly population assessed using multiplexed bead-based immunoassays.

Authors:  Hyun Ok Kim; Han-Soo Kim; Jong-Chan Youn; Eui-Cheol Shin; Sungha Park
Journal:  J Transl Med       Date:  2011-07-20       Impact factor: 5.531

2.  Unveiling the mechanisms for decreased glutathione in individuals with HIV infection.

Authors:  Devin Morris; Carlos Guerra; Clare Donohue; Hyoung Oh; Melissa Khurasany; Vishwanath Venketaraman
Journal:  Clin Dev Immunol       Date:  2011-12-29

3.  Investigating the causes for decreased levels of glutathione in individuals with type II diabetes.

Authors:  Minette Lagman; Judy Ly; Tommy Saing; Manpreet Kaur Singh; Enrique Vera Tudela; Devin Morris; Po-Ting Chi; Cesar Ochoa; Airani Sathananthan; Vishwanath Venketaraman
Journal:  PLoS One       Date:  2015-03-19       Impact factor: 3.240

4.  Liposomal Glutathione Supplementation Restores TH1 Cytokine Response to Mycobacterium tuberculosis Infection in HIV-Infected Individuals.

Authors:  Judy Ly; Minette Lagman; Tommy Saing; Manpreet Kaur Singh; Enrique Vera Tudela; Devin Morris; Jessica Anderson; John Daliva; Cesar Ochoa; Nishita Patel; Daniel Pearce; Vishwanath Venketaraman
Journal:  J Interferon Cytokine Res       Date:  2015-07-02       Impact factor: 2.607

5.  Analysis of glutathione levels in the brain tissue samples from HIV-1-positive individuals and subject with Alzheimer's disease and its implication in the pathophysiology of the disease process.

Authors:  Tommy Saing; Minette Lagman; Jeffery Castrillon; Eutiquio Gutierrez; Frederick T Guilford; Vishwanath Venketaraman
Journal:  BBA Clin       Date:  2016-05-29
  5 in total
  2 in total

1.  Factors Associated With Persistence of Plasma HIV-1 RNA During Long-term Continuously Suppressive Firstline Antiretroviral Therapy.

Authors:  Alessandra Ruggiero; Alessandro Cozzi-Lepri; Apostolos Beloukas; Douglas Richman; Saye Khoo; Andrew Phillips; Anna Maria Geretti
Journal:  Open Forum Infect Dis       Date:  2018-02-03       Impact factor: 3.835

2.  Cell-Mediated Immune Predictors of Vaccine Effect on Viral Load and CD4 Count in a Phase 2 Therapeutic HIV-1 Vaccine Clinical Trial.

Authors:  Yunda Huang; Giuseppe Pantaleo; Gonzalo Tapia; Brittany Sanchez; Lily Zhang; Monica Trondsen; Arnt-Ove Hovden; Richard Pollard; Jürgen Rockstroh; Mats Ökvist; Maja A Sommerfelt
Journal:  EBioMedicine       Date:  2017-09-22       Impact factor: 8.143

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.